INCREASED SERUM LEVELS OF FIBRINOGEN DEGRADATION PRODUCTS DUE TO TREATMENT WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION ARE RELATED TO BLEEDING COMPLICATIONS, BUT NOT TO CORONARY PATENCY

被引：39

作者：

ARNOLD, AER

BROWER, RW

COLLEN, D

VANES, GA

LUBSEN, J

SERRUYS, PW

SIMOONS, ML

VERSTRAETE, M

机构：

[1] ERASMUS UNIV,THORAXCTR,3000 DR ROTTERDAM,NETHERLANDS

[2] CATHOLIC UNIV LEUVEN,CTR THROMBOSIS & VASC RES,B-3000 LOUVAIN,BELGIUM

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1989年 / 14卷 / 03期

关键词：

D O I：

10.1016/0735-1097(89)90096-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：581 / 588

页数：8

共 24 条

[1] INTERACTION OF HEPARIN WITH PLASMINOGEN ACTIVATORS AND PLASMINOGEN - EFFECTS ON THE ACTIVATION OF PLASMINOGEN [J].

ANDRADEGORDON, P ;

STRICKLAND, S .

BIOCHEMISTRY, 1986, 25 (14) :4033-4040

[2] RELATION OF EFFECTIVENESS OF INTRACORONARY THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION TO SYSTEMIC THROMBOLYTIC STATE [J].

BURKET, MW ;

SMITH, MR ;

WALSH, TE ;

BREWSTER, PS ;

FRAKER, TD .

AMERICAN JOURNAL OF CARDIOLOGY, 1985, 56 (07) :441-444

[3] ENHANCEMENT OF THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY PRETREATMENT WITH HEPARIN [J].

CERCEK, B ;

LEW, AS ;

HOD, H ;

YANO, J ;

REDDY, NKN ;

GANZ, W .

CIRCULATION, 1986, 74 (03) :583-587

[4] THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].

CHESEBRO, JH ;

KNATTERUD, G ;

ROBERTS, R ;

BORER, J ;

COHEN, LS ;

DALEN, J ;

DODGE, HT ;

FRANCIS, CK ;

HILLIS, D ;

LUDBROOK, P ;

MARKIS, JE ;

MUELLER, H ;

PASSAMANI, ER ;

POWERS, ER ;

RAO, AK ;

ROBERTSON, T ;

ROSS, A ;

RYAN, TJ ;

SOBEL, BE ;

WILLERSON, J ;

WILLIAMS, DO ;

ZARET, BL ;

BRAUNWALD, E .

CIRCULATION, 1987, 76 (01) :142-154

[5] ANALYSIS OF COAGULATION AND FIBRINOLYSIS DURING INTRAVENOUS-INFUSION OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION [J].

COLLEN, D ;

BOUNAMEAUX, H ;

DECOCK, F ;

LIJNEN, HR ;

VERSTRAETE, M .

CIRCULATION, 1986, 73 (03) :511-517

[6]

DECLERCK P, 1987, THROMB HAEMOSTASIS, V58, P231

[7]

GOLDHABER SZ, 1988, LANCET, V2, P293

[8] INTERMITTENT CORONARY-OCCLUSION IN ACUTE MYOCARDIAL-INFARCTION - VALUE OF COMBINED THROMBOLYTIC AND VASODILATOR THERAPY [J].

HACKETT, D ;

DAVIES, G ;

CHIERCHIA, S ;

MASERI, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (17) :1055-1059

[9] OBTAINING CONFIDENCE-INTERVALS FOR RISK RATIO IN COHORT STUDIES [J].

KATZ, D ;

BAPTISTA, J ;

AZEN, SP ;

PIKE, MC .

BIOMETRICS, 1978, 34 (03) :469-474

[10]

MIETTINEN OS, 1985, THEORETICAL EPIDEMIO, P235

← 1 2 3 →